Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

NCT07173244 is registered in ClinicalTrials.gov with Tianjin First Central Hospital as lead sponsor.

NCT NCT07173244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
Lead sponsor
Tianjin First Central Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 15, 2025
Completion date
September 30, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancers, non-small cell lung cancer, small cell lung cancer